Slowing of brain atrophy with teriflunomide
Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite Multiple sclerosis.
MAT-BH-2200911-Nov 22
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite Multiple sclerosis.
MAT-BH-2200911-Nov 22
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.